GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Vimta Labs Ltd (NSE:VIMTALABS) » Definitions » Price-to-Owner-Earnings

Vimta Labs (NSE:VIMTALABS) Price-to-Owner-Earnings : 37.13 (As of Jul. 19, 2025)


View and export this data going back to 2005. Start your Free Trial

What is Vimta Labs Price-to-Owner-Earnings?

As of today (2025-07-19), Vimta Labs's share price is ₹525.35. Vimta Labs's Owner Earnings per Share (TTM) ended in Mar. 2025 was ₹14.15. It's Price-to-Owner-Earnings for today is 37.13.


The historical rank and industry rank for Vimta Labs's Price-to-Owner-Earnings or its related term are showing as below:

NSE:VIMTALABS' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 7.74   Med: 19.87   Max: 38.35
Current: 37.12

During the past 13 years, the highest Price-to-Owner-Earnings of Vimta Labs was 38.35. The lowest was 7.74. And the median was 19.87.


NSE:VIMTALABS's Price-to-Owner-Earnings is ranked worse than
57.53% of 73 companies
in the Medical Diagnostics & Research industry
Industry Median: 28.44 vs NSE:VIMTALABS: 37.12

As of today (2025-07-19), Vimta Labs's share price is ₹525.35. Vimta Labs's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2025 was ₹16.41. Therefore, Vimta Labs's PE Ratio (TTM) for today is 32.01.

As of today (2025-07-19), Vimta Labs's share price is ₹525.35. Vimta Labs's EPS without NRI for the trailing twelve months (TTM) ended in was ₹16.03. Therefore, Vimta Labs's PE Ratio without NRI for today is 32.76.

During the past 13 years, Vimta Labs's highest PE Ratio without NRI was 77.46. The lowest was 6.76. And the median was 23.41.


Vimta Labs Price-to-Owner-Earnings Historical Data

The historical data trend for Vimta Labs's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vimta Labs Price-to-Owner-Earnings Chart

Vimta Labs Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only 18.38 16.23 11.75 30.36 35.30

Vimta Labs Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 35.30 -

Competitive Comparison of Vimta Labs's Price-to-Owner-Earnings

For the Diagnostics & Research subindustry, Vimta Labs's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vimta Labs's Price-to-Owner-Earnings Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Vimta Labs's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Vimta Labs's Price-to-Owner-Earnings falls into.


;
;

Vimta Labs Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Vimta Labs's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=525.35/14.15
=37.13

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Vimta Labs  (NSE:VIMTALABS) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Vimta Labs Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Vimta Labs's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Vimta Labs Business Description

Traded in Other Exchanges
Address
Plot No.141/2 & 142, IDA, Phase-II, Cherlapally, R. R. District, Hyderabad, TG, IND, 500051
Vimta Labs Ltd is a comprehensive contract research and testing organization, providing a wide range of services to pharmaceutical, biopharmaceutical, food, consumer goods, electronic, electrical, agrochemical, healthcare, medical device, and many other industries. Its services portfolio includes testing and contract research services in the fields of clinical research, pre-clinical research, clinical diagnostics, biopharma services, analytical testing, research and environmental studies, and Others. It has only one reportable segment namely Contract Research and Testing Services which generates the revenue.

Vimta Labs Headlines

No Headlines